Advantages of an antagonist: Bicuculline and other GABA antagonists

British Journal of Pharmacology

Volumn 169, Issue 2, 2013, Pages 328-336

  Johnston, Graham A R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

antagonists; bicuculline; GABA receptors; gabazine; picrotoxin

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 3ALPHA HYDROXY 16 IMINO 5BETA 17 AZAANDROSTAN 11 ONE; 4 (3 BIPHENYL) 5 (4 PIPERIDYL) 3 ISOXAZOLE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BICUCULLINE; BICUCULLINE METHIODIDE; PICROTOXIN; PICROTOXININ; SALICYLIDENE SALICYLHYDRAZIDE; UNCLASSIFIED DRUG;

DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STABILITY; DRUG STRUCTURE; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; SYNAPTIC INHIBITION;

ANIMALS; BICUCULLINE; CONVULSANTS; DRUG DESIGN; GABA ANTAGONISTS; GABA-A RECEPTOR ANTAGONISTS; HUMANS; MOLECULAR BIOLOGY; RECEPTORS, GABA; RECEPTORS, GABA-A;

EID: 84876903429     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12127     Document Type: Review

References (68)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Andrews PR, Johnston GAR, (1979). GABA agonists and antagonists. Biochem Pharmacol 28: 2697-2702.
3. Beart PM, Johnston GAR, (1972). Bicuculline and GABA-metabolising enzymes. Brain Res 38: 226-227.
4. C receptors. Trends Neurosci 18: 515-519.
5. C receptors: structure, function and pharmacology. Handb Exp Pharmacol 150: 271-296.
6. Braun M, Ramracheya R, Bengtsson M, Clark A, Walker JN, Johnson PR, et al. (2010). γ-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells. Diabetes 59: 1694-1701.
7. Breuker E, Johnston GAR, (1975). Inhibition of acetylcholinesterase by bicuculline and related alkaloids. J Neurochem 25: 903-904.
8. Chebib M, Johnston GAR, (2000). GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem 43: 1427-1447.
9. Curtis DR, (2006). David R. Curtis Autobiography. Hist Neurosci Autobiogr 5: 171-225.
10. Curtis DR, Hosli L, Johnston GAR, (1967). Inhibition of spinal neurons by glycine. Nature 215: 1502-1503.
11. Curtis DR, Duggan AW, Johnston GAR, (1969). Glycine, strychnine, picrotoxin and spinal inhibition. Brain Res 14: 759-762.
12. Curtis DR, Duggan AW, Felix D, Johnston GAR, (1970a). Bicuculline and central GABA receptors. Nature 228: 676-677.
13. Curtis DR, Duggan AW, Felix D, Johnston GAR, (1970b). GABA, bicuculline and central inhibition. Nature 226: 1222-1224.
14. Curtis DR, Duggan AW, Felix D, Johnston GAR, (1971). Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res 32: 69-96.
15. Davidoff RA, Aprison MH, (1968). Picrotoxin antagonism of the inhibition of interneurons by glycine. Life Sci 8: 107-112.
16. DeFeudis FV, (2002). Bilobalide and neuroprotection. Pharmacol Res 46: 565-568.
17. Demuro A, Palma E, Eusebi F, Miledi R, (2001). Inhibition of nicotinic acetylcholine receptors by bicuculline. Neuropharmacology 41: 854-861.
18. Drew CA, Johnston GAR, Weatherby RP, (1984). Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes. Neurosci Lett 52: 317-321.
19. Ebert B, Thompson SA, Saounatsou K, McKernan R, Krogsgaard-Larsen P, Wafford KA, (1997). Differences in agonist/antagonist binding affinity and receptor transduction using recombinant human γ-aminobutyric acid type A receptors. Mol Pharmacol 52: 1150-1156.
20. Eccles JC, Schmidt R, Willis RD, (1963). Pharmacological studies on presynaptic inhibition. J Physiol 168: 500-530.
21. Editorial (1970). Advantages of an antagonist. Nature 226: 1199-1200.
22. Freund RK, Marley RJ, Wehnder JM, (1987). Differential sensitivity to bicuculline in three inbred mouse strains. Brain Res Bull 18: 657-662.
23. A antagonists: synthesis, pharmacology, and structure-activity relationships. J Med Chem 50: 1988-1992.
24. C receptor function. Br J Pharmacol 167: 1369-1377.
25. Godfraind JM, Krnjevic K, Pumain R, (1970). Doubtful value of bicuculline as a specific antagonist of GABA. Nature 228: 675-676.
26. Hanrahan JR, Johnston GAR, (2009). Synthesis of γ-aminobutyric acid analogues. In:, Hughes AB, (ed.). Amino Acids, Peptides and Proteins in Organic Chemistry. Vol. Voliume 1, Origins and synthesis of amino acids. Wiley VCH: Weinheim, pp. 573-689.
27. Hawthorne R, Cromer BA, Ng HL, Parker MW, Lynch JW, (2006). Molecular determinants of ginkgolide binding in the glycine receptor pore. J Neurochem 98: 395-407.
28. A receptor site. Brain Res 384: 224-231.
29. 3H-GABA bind to bicuculline insensitive GABA sites in rat brain. Nature 290: 149-152.
30. Hill RG, Simmonds MA, Straughan DW, (1973). A comparative study of some convulsant substances as γ-aminobutyric acid antagonists in the feline cerebral cortex. Br J Pharmacol 49: 37-51.
31. Hoffman M, (1994). Lost in the cultural revolution. Am Sci 82: 18-19.
32. Huang M, Qian Y, Guan T, Huang L, Tang X, Li Y, (2012). Different neuroprotective responses of Ginkgolide B and bilobalide, the two Ginkgo components, in ischemic rats with hyperglycemia. Eur J Pharmacol 677: 71-76.
33. A receptors. Eur J Pharmacol 464: 1-8.
34. Hunt P, Clements-Jewery S, (1981). A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction. Neuropharmacology 20: 357-361.
35. A receptor antagonists based on gabazine (SR-95531). Bioorg Med Chem Lett 21: 4252-4254.
36. A receptors. J Biol Chem 278: 49279-49285.
37. Johns L, Sinclair AJ, Davies JA, (2002). Effects of bilobalide on hypoxia/hypoglycemia-stimulated glutamate efflux from rat cortical brain slices. Neurochem Res 27: 369-371.
38. Johnston GAR, (1985). First Sino-Australian workshop in pharmacology. Trends Pharmacol Sci 159.
39. A antagonists. Semin Neurosci 3: 205-210.
40. C receptors: relatively simple transmitter-gated ion channels? Trends Pharmacol Sci 17: 319-323.
41. Johnston GAR, Beart PM, Curtis DR, Game CJ, McCulloch RM, Maclachlan RM, (1972). Bicuculline methochloride as a GABA antagonist. Nat New Biol 240: 219-220.
42. A receptors. Neuropharmacology 35: 1289-1298.
43. C receptors confer distinct temporal properties to retinal synaptic responses. J Neurophysiol 79: 3157-3167.
44. A receptor main conductance state of mouse spinal cord neurones in culture. J Physiol (Lond) 419: 479-499.
45. McLennan H, (1970). Bicuculline and inhibition of crayfish stretch receptor neurones. Nature 228: 674-675.
46. C receptors. Future Med Chem 3: 197-209.
47. Olsen RW, Sieghart W, (2008). International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acid (A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60: 243-260.
48. Olsen RW, Sieghart W, (2009). GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56: 141-148.
49. Olsen RW, Ban M, Miller T, Johnston GAR, (1975). Chemical instability of the GABA antagonist bicuculline under physiological conditions. Brain Res 98: 383-387.
50. Owens DF, Kriegstein AR, (2002). Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3: 715-727.
51. Pong SF, Graham LT, (1972). N-methyl bicuculline, a convulsant more potent than bicuculline. Brain Res 42: 486-490.
52. Roberts E, Kuriyama K, Haber B, (1970). Biochemistry of synaptic inhibition at the cellular level: the GABA system. Adv Biochem Psychopharmacol 2: 139-161.
53. Sasaki K, Hatta S, Haga M, Ohshika H, (1999a). Effects of bilobalide on γ-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain. Eur J Pharmacol 367: 165-173.
54. Sasaki K, Oota I, Wada K, Inomata K, Ohshika H, Haga M, (1999b). Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices. Comp Biochem Physiol C Comp Pharmacol Toxicol 124: 315-321.
55. Seutin V, Johnson SW, (1999). Recent advances in the pharmacology of quaternary salts of bicuculline. Trends Pharmacol Sci 20: 268-270.
56. A receptor and dysregulation of p130cas phosphorylation. Am J Physiol Cell Physiol 296: C1400-C1410.
57. Sigel E, Baur R, Kellenberger S, Malherbe P, (1992). Point mutations affecting antagonist affinity and agonist dependent gating of GABA receptor channels. EMBO J 11: 2017-2023.
58. Simmonds MA, Turner JP, (1985). Antagonism of inhibitory amino acids by the steroid derivative RU5135. Br J Pharmacol 84: 631-635.
59. Thompson AJ, Lester HA, Lummis SC, (2010). The structural basis of function in Cys-loop receptors. Q Rev Biophys 43: 449-499.
60. 3 receptor at a location that overlaps the picrotoxin binding site. Neuropharmacology 60: 488-495.
61. A receptors. Br J Pharmacol 142: 97-106.
62. Tian J, Chau C, Hales TG, Kaufman DL, (1999). GABAA receptors mediate inhibition of T cell responses. J Neuroimmunol 96: 21-28.
63. Tsou K, (1987). Mechanism of morphine analgesia and hybridization approaches to study the role of opioid peptides in acupuncture. In:, Rand MJ, Raper C, (eds). Pharmacology-Proceedings of the Xth International Congress of Pharmacology, Edn. Elsevier: Sydney, pp. 225-234.
64. Uchida I, Cestari IN, Yang J, (1996). The differential antagonism by bicuculline and SR95531 of pentobarbitone-induced currents un cultured hippocampal neurons. Eur J Pharmacol 307: 89-96.
65. A receptor. J Neurosci 17: 625-634.
66. Welch AD, Henderson VE, (1934). A note on bicucine. J Pharmacol Exp Ther 51: 492-494.
67. Werman R, Davidoff RA, Aprison MH, (1967). Inhibition of motoneurones by iontophoresis of glycine. Nature 214: 581-583.
68. A receptors. Mol Pharmacol 74: 941-951.